Keyphrases
Risk Factors
100%
Antiretroviral Therapy
100%
Resistance mutations
100%
UK Data
100%
HIV Drug Resistance
100%
Risk Outcomes
100%
Viral Suppression
66%
Viral Load
66%
Negative Association
66%
Insertion mutation
66%
Boosted Protease Inhibitors
66%
Viral
33%
Blood Samples
33%
High-income Countries
33%
Negatively Associated
33%
Drug Resistance
33%
Low-middle Income Countries
33%
Virological Failure
33%
Patient Outcomes
33%
Further Analysis
33%
Nucleosides
33%
Stavudine
33%
HIV Cohort
33%
Matched Case-control
33%
Control Approach
33%
Experienced Patients
33%
Reverse Transcriptase Inhibitors
33%
Survival Analysis
33%
Reverse Transcriptase Gene
33%
Didanosine
33%
Treatment History
33%
Historic Samples
33%
Patient Analysis
33%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus 1
100%
Human Immunodeficiency Virus
100%
Virus Load
100%
Drug Resistance
100%
Reverse Transcriptase
100%
Protease Inhibitor
100%
CD4
100%
Prevalence
50%
Cohort Study
50%
Gene Linkage
50%
Nucleoside
50%
Didanosine
50%
Stavudine
50%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Resistance Mutation
100%
Antiretroviral Therapy
100%
Proteinase Inhibitor
66%
Prevalence
33%
Drug Resistance
33%
Cohort Analysis
33%
Gene Linkage
33%
Survival Analysis
33%
Low and Middle Income Countries
33%
Stavudine
33%
Reverse-Transcriptase Inhibitor
33%
RNA Directed DNA Polymerase
33%
HIV Drug Resistance
33%
Nucleoside
33%
Didanosine
33%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Proteinase Inhibitor
66%
Cohort Study
33%
Prevalence
33%
Drug Resistance
33%
Nucleoside
33%
Stavudine
33%
RNA Directed DNA Polymerase Inhibitor
33%
RNA Directed DNA Polymerase
33%
HIV Drug Resistance
33%
Didanosine
33%
Neuroscience
Human Immunodeficiency Virus
100%
Proteinase
50%
Drug Resistance
50%
CD4
50%
Reverse Transcriptase
25%
Nucleoside
25%
Reverse Transcriptase Inhibitors
25%
Survival Analysis
25%
Stavudine
25%
Didanosine
25%